Items where authors include "Ford, AC"
Up a levelArticle
Black, CJ, Ng, C-E, Goodoory, VC orcid.org/0000-0001-9483-5604 et al. (1 more author) (2024) Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden. Clinical Gastroenterology and Hepatology, 22 (2). pp. 386-396. ISSN 1542-3565
Porcari, S, Baunwall, SMD, Occhionero, AS et al. (6 more authors) (2023) Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: A systematic review and meta-analysis. Journal of Autoimmunity, 141. 103036. ISSN 0896-8411
Wise, J, Ingrosso, MR, Ianiro, G et al. (3 more authors) (2023) Response and Adverse Event Rates with Placebo in Gastroparesis: A Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology, 21 (6). pp. 1447-1461. ISSN 1542-3565
Black, CJ, McKenzie, YA, Scofield-Marlowe, M et al. (4 more authors) (2023) Top 10 research priorities for irritable bowel syndrome: results of a James Lind Alliance priority setting partnership. The Lancet Gastroenterology and Hepatology, 8 (6). pp. 499-501. ISSN 2468-1253
Gunn, D, Topan, R, Barnard, L orcid.org/0000-0001-5436-6882 et al. (19 more authors) (2023) Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial. Alimentary Pharmacology & Therapeutics, 57 (11). pp. 1258-1271. ISSN 0269-2813
Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2023) Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (10). pp. 1083-1092. ISSN 0269-2813
Ingrosso, MR, Camilleri, M, Tack, J et al. (3 more authors) (2023) Efficacy and Safety of Drugs for Gastroparesis: Systematic Review and Network Meta-analysis. Gastroenterology, 164 (4). pp. 642-654. ISSN 0016-5085
Knowles, SR, Skvarc, D, Ford, AC orcid.org/0000-0001-6371-4359 et al. (4 more authors) (2023) Negative Impact of Disorders of Gut-Brain Interaction on Health-related Quality of Life: Results from the Rome Foundation Global Epidemiology Survey. Gastroenterology, 164 (4). pp. 655-668. ISSN 0016-5085
Din, S, Selinger, CP, Black, CJ et al. (1 more author) (2023) Systematic review with network meta-analysis: Risk of Herpes zoster with biological therapies and small molecules in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 57 (6). pp. 666-675. ISSN 0269-2813
Fairbrass, KM, Guthrie, EA orcid.org/0000-0002-5834-6616, Black, CJ et al. (3 more authors) (2023) Characteristics and Impact of Anxiety and Depression Trajectories in Inflammatory Bowel Disease. American Journal of Gastroenterology, 118 (2). pp. 304-316. ISSN 0002-9270
Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Efficacy of biological therapies and small molecules in induction and maintenance of remission in luminal Crohn’s disease: systematic review and network meta-analysis. Gut, 72 (2). pp. 264-274. ISSN 0017-5749
Visaggi, P, Ghisa, M, Barberio, B et al. (7 more authors) (2023) Treatment Trends for Eosinophilic Esophagitis and the Other Eosinophilic Gastrointestinal Diseases: Systematic Review of Clinical Trials. Digestive and Liver Disease, 55 (2). pp. 208-222. ISSN 1590-8658
Goodoory, VC orcid.org/0000-0001-9483-5604, Guthrie, EA orcid.org/0000-0002-5834-6616, Ng, CE et al. (2 more authors) (2023) Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 57 (3). pp. 323-334. ISSN 0269-2813
Barberio, B, Gracie, DJ, Black, CJ et al. (1 more author) (2023) Impact of Baseline Disease Activity and Trial Duration on Efficacy of Biologics in Active Crohn’s Disease: Meta-analysis. Inflammatory Bowel Diseases. izac263. ISSN 1078-0998
Alderson, SL orcid.org/0000-0002-5418-0495, Wright-Hughes, A, Ford, AC orcid.org/0000-0001-6371-4359 et al. (20 more authors) (2022) Amitriptyline at low-dose and titrated for irritable bowel syndrome as second-line treatment (The ATLANTIS trial): protocol for a randomised double-blind placebo-controlled trial in primary care. Trials, 23 (1). 552. ISSN 1745-6215
Black, CJ, Houghton, LA orcid.org/0000-0002-5351-0229 and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Latent class analysis does not support the existence of Rome IV functional bowel disorders as discrete entities. Neurogastroenterology & Motility, 34 (11). e14391. ISSN 1350-1925
Ford, AC orcid.org/0000-0001-6371-4359, Tsipotis, E, Yuan, Y et al. (2 more authors) (2022) Efficacy of Helicobacter pylori eradication therapy for functional dyspepsia: updated systematic review and meta-analysis. Gut, 71 (10). pp. 1967-1975. ISSN 0017-5749
Burr, NE, Gracie, DJ, Black, CJ et al. (1 more author) (2022) Efficacy of biological therapies and small molecules in moderate to severe ulcerative colitis: systematic review and network meta-analysis. Gut, 71 (10). pp. 1976-1987. ISSN 0017-5749
Fairbrass, KM, Hamlin, PJ, Gracie, DJ et al. (1 more author) (2022) Natural history and impact of irritable bowel syndrome-type symptoms in inflammatory bowel disease during 6 years of longitudinal follow-up. Alimentary Pharmacology and Therapeutics, 56 (8). pp. 1264-1273. ISSN 0269-2813
Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Willingness to pay for medications among patients with Rome IV Irritable Bowel Syndrome. Neurogastroenterology & Motility. e14483. ISSN 1350-1925
Ford, AC orcid.org/0000-0001-6371-4359, Yuan, Y and Moayyedi, P (2022) Long-term impact of Helicobacter pylori eradication therapy on gastric cancer incidence and mortality in healthy infected individuals: A meta-analysis beyond 10 years of follow-up. Gastroenterology, 163 (3). pp. 754-756. ISSN 0016-5085
Fairbrass, KM orcid.org/0000-0002-5569-4762, Lovatt, J, Barberio, B et al. (3 more authors) (2022) Bidirectional brain–gut axis effects influence mood and prognosis in IBD: a systematic review and meta-analysis. Gut, 71 (9). pp. 1773-1780. ISSN 0017-5749
Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Impact of Rome IV Irritable Bowel Syndrome on Work and Activities of Daily Living. Alimentary Pharmacology and Therapeutics (AP&T), 56 (5). pp. 844-856. ISSN 0269-2813
Ingrosso, MR, Ianiro, G, Nee, J et al. (4 more authors) (2022) Systematic review and meta‐analysis: efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 56 (6). pp. 932-941. ISSN 0269-2813
Black, CJ, Paine, PA, Agrawal, A et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749
Eusebi, LH, Telese, A, Cirota, GG et al. (4 more authors) (2022) Effect of Gastro-esophageal Reflux Symptoms on the Risk of Barrett’s Esophagus: A Systematic Review and Meta-analysis. Journal of Gastroenterology and Hepatology, 37 (8). pp. 1507-1516. ISSN 0815-9319
Savarino, E, Zingone, F, Barberio, B et al. (27 more authors) (2022) Functional bowel disorders with diarrhoea: Clinical guidelines of the United European Gastroenterology and European Society for Neurogastroenterology and Motility. United European Gastroenterology Journal, 10 (6). pp. 556-584. ISSN 2050-6406
Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Alimentary Pharmacology & Therapeutics, 56 (1). pp. 110-120. ISSN 0269-2813
Fairbrass, KM, Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Relative Contribution of Disease Activity and Psychological Health to Prognosis of Inflammatory Bowel Disease During 6.5 Years of Longitudinal Follow-Up. Gastroenterology, 163 (1). pp. 190-203. ISSN 0016-5085
Goodoory, VC orcid.org/0000-0001-9483-5604, Craig, OF, Gracie, DJ et al. (2 more authors) (2022) Prognosis of patients with Rome IV‐defined versus physician‐diagnosed irritable bowel syndrome: Longitudinal follow‐up study. Neurogastroenterology & Motility, 34 (6). e14282. ISSN 1350-1925
Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis. Neurogastroenterology & Motility, 34 (6). e14279. ISSN 1350-1925
Black, CJ, Staudacher, HM and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis. Gut, 71 (6). pp. 1117-1126. ISSN 0017-5749
Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2022) Assessing the Impact of Changes to the Rome IV Criteria for Clinical Practice in Irritable Bowel Syndrome. Gastroenterology, 162 (6). 1752-1754.e1. ISSN 0016-5085
Goodoory, VC orcid.org/0000-0001-9483-5604, Houghton, LA orcid.org/0000-0002-5351-0229, Black, CJ et al. (1 more author) (2022) Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders. Neurogastroenterology & Motility, 34 (5). e14268. ISSN 1350-1925
Barberio, B, Savarino, EV, Black, CJ et al. (1 more author) (2022) Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis. Clinical Gastroenterology and Hepatology, 20 (5). E923-E944. ISSN 1542-3565
Fairbrass, KM orcid.org/0000-0002-5569-4762, Selinger, CP, Gracie, DJ et al. (1 more author) (2022) Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Neurogastroenterology & Motility, 34 (5). e14256. ISSN 1350-1925
Goodoory, VC orcid.org/0000-0001-9483-5604, Ng, CE, Black, CJ et al. (1 more author) (2022) Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 55 (10). pp. 1311-1319. ISSN 0269-2813
Barberio, B, Facchin, S, Patuzzi, I et al. (8 more authors) (2022) A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach. Gut Microbes, 14 (1). e2028366. ISSN 1949-0976
Barberio, B, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2022) Overlap of Rome IV Irritable Bowel Syndrome and Functional Dyspepsia and Effect on Natural History: A Longitudinal Follow-up Study. Clinical Gastroenterology and Hepatology, 20 (2). E89-E101. ISSN 1542-3565
Barberio, B, Massimi, D, Cazzagon, N et al. (3 more authors) (2021) Prevalence of Primary Sclerosing Cholangitis in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. Gastroenterology, 161 (6). pp. 1865-1877. ISSN 0016-5085
Zamani, M, Alizadeh‐Tabari, S, Hasanpour, AH et al. (2 more authors) (2021) Systematic review with meta-analysis: association of Helicobacter pylori infection with gastro-oesophageal reflux and its complications. Alimentary Pharmacology & Therapeutics, 54 (8). pp. 988-998. ISSN 0269-2813
Sagar, R, Lenti, MV, Clark, T et al. (7 more authors) (2021) Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Virtual Biologics Clinic Leads to Durable Clinical Results. Inflammatory Intestinal Diseases, 6 (3). pp. 132-139. ISSN 2296-9403
Klaassen, T, Smeets, FGM, Vork, L et al. (10 more authors) (2021) Psychometric evaluation of an experience sampling method–based patient-reported outcome measure in functional dyspepsia. Neurogastroenterology & Motility, 33 (9). e14136. ISSN 1350-1925
Ferreira, N, Mikocka-Walus, A, van Tilburg, MAL et al. (17 more authors) (2021) The impact of the coronavirus (COVID-19) pandemic on individuals with gastrointestinal disorders: A protocol of an international collaborative study. Journal of Psychosomatic Research, 148. 110561. ISSN 0022-3999
Fairbrass, KM, Gracie, DJ and Ford, AC (2021) Longitudinal follow‐up study: effect of psychological co‐morbidity on the prognosis of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 54 (4). pp. 441-450. ISSN 0269-2813
Tasson, L, Zingone, F, Barberio, B et al. (7 more authors) (2021) Sarcopenia, severe anxiety and increased C-reactive protein are associated with severe fatigue in patients with inflammatory bowel diseases. Scientific Reports, 11 (1). 15251. ISSN 2045-2322
Barberio, B, Segal, JP, Quraishi, MN et al. (3 more authors) (2021) Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-analysis. Journal of Crohn's and Colitis, 15 (7). pp. 1184-1196. ISSN 1873-9946
Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2021) Best management of irritable bowel syndrome. Frontline Gastroenterology, 12. pp. 303-315. ISSN 2041-4137
Vasant, DH, Paine, PA, Black, CJ et al. (10 more authors) (2021) British Society of Gastroenterology guidelines on the management of irritable bowel syndrome. Gut, 70 (7). pp. 1214-1240. ISSN 0017-5749
Nelson, AD, Black, CJ, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2021) Editorial: recognising the efficacy of licensed drug therapies for irritable bowel syndrome on bloating—a step in the right direction for targeted treatment? Authors' reply. Alimentary Pharmacology & Therapeutics, 54 (2). pp. 198-199. ISSN 0269-2813
Nelson, AD, Black, CJ, Houghton, LA et al. (3 more authors) (2021) Systematic review and network meta‐analysis: efficacy of licensed drugs for abdominal bloating in irritable bowel syndrome with constipation. Alimentary Pharmacology & Therapeutics, 54 (2). pp. 98-108. ISSN 0269-2813
Barberio, B, Judge, C, Savarino, EV et al. (1 more author) (2021) Global prevalence of functional constipation according to the Rome criteria: a systematic review and meta-analysis. The Lancet Gastroenterology and Hepatology. ISSN 2468-1253
Goodoory, VC orcid.org/0000-0001-9483-5604, Houghton, LA orcid.org/0000-0002-5351-0229, Yiannakou, Y et al. (2 more authors) (2021) Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study. Clinical Gastroenterology and Hepatology. ISSN 1542-3565
Barberio, B, Zamani, M, Black, CJ et al. (2 more authors) (2021) Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 6 (5). pp. 359-370. ISSN 2468-1253
Black, CJ, Yiannakou, Y, Guthrie, E orcid.org/0000-0002-5834-6616 et al. (3 more authors) (2021) Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value. Alimentary Pharmacology and Therapeutics, 53 (10). pp. 1126-1137. ISSN 0269-2813
Eusebi, LH, Telese, A, Cirota, GG et al. (4 more authors) (2021) Systematic review with meta‐analysis: risk factors for Barrett's oesophagus in individuals with gastro‐oesophageal reflux symptoms. Alimentary Pharmacology and Therapeutics, 53 (9). pp. 968-976. ISSN 0269-2813
Goodoory, VC, Mikocka-Walus, A, Yiannakou, Y et al. (3 more authors) (2021) Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome. American Journal of Gastroenterology. ISSN 0002-9270
Eusebi, LH, Cirota, GG, Zagari, RM et al. (1 more author) (2021) Global prevalence of Barrett’s oesophagus and oesophageal cancer in individuals with gastro-oesophageal reflux: a systematic review and meta-analysis. Gut, 70 (3). pp. 456-463. ISSN 0017-5749
Ruffle, JK, Tinkler, L, Emmett, C et al. (5 more authors) (2021) Constipation Predominant Irritable Bowel Syndrome and Functional Constipation Are Not Discrete Disorders: A Machine Learning Approach. American Journal of Gastroenterology, 116 (1). pp. 142-151. ISSN 0002-9270
Mundre, P, Black, CJ, Mohammed, N et al. (1 more author) (2021) Efficacy of surgical or endoscopic treatment of idiopathic achalasia: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 6 (1). pp. 30-38. ISSN 2468-1253
Ford, AC orcid.org/0000-0001-6371-4359, Moayyedi, P, Black, CJ et al. (6 more authors) (2021) Systematic review and network meta-analysis: efficacy of drugs for functional dyspepsia. Alimentary Pharmacology & Therapeutics, 53 (1). pp. 8-21. ISSN 0269-2813
Ford, AC orcid.org/0000-0001-6371-4359, Yuan, Y and Moayyedi, P (2020) Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut, 69 (12). pp. 2113-2121. ISSN 0017-5749
Fairbrass, KM orcid.org/0000-0002-5569-4762, Costantino, SJ, Gracie, DJ et al. (1 more author) (2020) Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 5 (12). pp. 1053-1062. ISSN 2468-1253
Barberio, B, Black, CJ, Savarino, EV et al. (1 more author) (2020) Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis. Journal of Crohn's and Colitis. ISSN 1873-9946
Black, CJ, Yiannakou, Y, Guthrie, EA et al. (3 more authors) (2020) A Novel Method to Classify and Subgroup Patients With IBS Based on Gastrointestinal Symptoms and Psychological Profiles. American Journal of Gastroenterology. ISSN 0002-9270
Ford, AC orcid.org/0000-0001-6371-4359, Mahadeva, S, Carbone, MF et al. (2 more authors) (2020) Functional dyspepsia. The Lancet. ISSN 0140-6736
Black, CJ, Drossman, DA, Talley, NJ et al. (2 more authors) (2020) Functional gastrointestinal disorders: advances in understanding and management. The Lancet. ISSN 0140-6736
Ford, AC orcid.org/0000-0001-6371-4359, Sperber, AD, Corsetti, M et al. (1 more author) (2020) Irritable bowel syndrome. The Lancet. ISSN 0140-6736
Barberio, B, Houghton, LA, Yiannakou, Y et al. (3 more authors) (2020) Symptom Stability in Rome IV vs Rome III Irritable Bowel Syndrome. American Journal of Gastroenterology. ISSN 0002-9270
Black, CJ, Craig, O, Gracie, DJ et al. (1 more author) (2020) Comparison of the Rome IV criteria with the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gut. ISSN 0017-5749
Barberio, B, Mahadeva, S, Black, CJ et al. (2 more authors) (2020) Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Alimentary Pharmacology & Therapeutics, 52 (5). pp. 762-773. ISSN 0269-2813
Black, CJ, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (4 more authors) (2020) Anxiety‐related factors associated with symptom severity in irritable bowel syndrome. Neurogastroenterology & Motility, 32 (8). e13872. ISSN 1350-1925
Black, CJ, Thakur, ER, Houghton, LA et al. (3 more authors) (2020) Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut, 69 (8). pp. 1441-1451. ISSN 0017-5749
Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nature Reviews Gastroenterology & Hepatology, 17. pp. 473-486. ISSN 1759-5045
Oka, P, Parr, H, Barberio, B et al. (3 more authors) (2020) Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. ISSN 2468-1253
Vasant, DH and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Functional gastrointestinal disorders in inflammatory bowel disease: Time for a paradigm shift? World Journal of Gastroenterology, 26 (26). pp. 3712-3719. ISSN 1007-9327
Ye, Y, Jiang, B, Manne, S et al. (5 more authors) (2020) Epidemiology and outcomes of gastroparesis, as documented in general practice records, in the United Kingdom. Gut. ISSN 0017-5749
Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982 and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Relative Efficacy of Tegaserod in a Systematic Review and Network Meta-analysis of Licensed Therapies for Irritable Bowel Syndrome with Constipation. Clinical Gastroenterology and Hepatology, 18 (5). 1238-1239.E1. ISSN 1542-3565
Fairbrass, KM orcid.org/0000-0002-5569-4762, Hoshen, D, Gracie, DJ orcid.org/0000-0001-9616-981X et al. (1 more author) (2020) Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease. Gut. ISSN 0017-5749
Ford, AC orcid.org/0000-0001-6371-4359 (2020) Overlap between irritable bowel syndrome and inflammatory bowel disease. Gastroenterology and Hepatology, 16 (4). pp. 211-213. ISSN 1554-7914
O’Connor, A, Gracie, DJ, Hamlin, PJ et al. (1 more author) (2020) Predictors of Dyspareunia Among Female Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 18 (4). pp. 1000-1001. ISSN 1542-3565
Black, CJ, Houghton, LA and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Efficacy of Eluxadoline in Irritable Bowel Syndrome With Diarrhea. American Journal of Gastroenterology, 115 (3). pp. 483-484. ISSN 0002-9270
Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2020) Rational investigations in irritable bowel syndrome. Frontline Gastroenterology, 11 (2). pp. 140-147. ISSN 2041-4137
Black, CJ, Yuan, Y, Selinger, CP et al. (4 more authors) (2020) Efficacy of soluble fibre, antispasmodic drugs, and gut–brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology and Hepatology, 5 (2). pp. 117-131. ISSN 2468-1253
Black, CJ, Yiannakou, Y, Houghton, LA et al. (1 more author) (2020) Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clinical Gastroenterology and Hepatology, 18 (2). pp. 392-398. ISSN 1542-3565
Selinger, C, Carbonell, J, Kane, J et al. (2 more authors) (2020) Acceptability of a ‘treat to target’ approach in inflammatory bowel disease to patients in clinical remission. Frontline Gastroenterology. ISSN 2041-4137
Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982, Camilleri, M et al. (5 more authors) (2020) Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut, 69 (1). pp. 74-82. ISSN 0017-5749
Eusebi, LH, Black, CJ, Howden, CW et al. (1 more author) (2019) Effectiveness of management strategies for uninvestigated dyspepsia: systematic review and network meta-analysis. BMJ, 367 (8226). l6483. ISSN 1756-1833
Ianiro, G, Murri, R, Sciumè, GD et al. (10 more authors) (2019) Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study. Annals of Internal Medicine, 171 (10). pp. 695-702. ISSN 0003-4819
Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2019) Crohn’s Disease Connectome Conundrums: Relevance to the Prevalence and Management of Mood Disorders. Gastroenterology, 157 (5). pp. 1429-1430. ISSN 0016-5085
Luthra, P, Camilleri, M, Burr, NE orcid.org/0000-0003-1988-2982 et al. (3 more authors) (2019) Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis. The lancet. Gastroenterology & Hepatology, 4 (11). pp. 831-844. ISSN 2468-1253
Black, CJ, Ford, AC orcid.org/0000-0001-6371-4359 and Houghton, LA (2019) Editorial: understanding differences in patient response to ondansetron in irritable bowel syndrome with diarrhoea-are we any closer? Alimentary Pharmacology & Therapeutics, 50 (7). pp. 825-826. ISSN 0269-2813
Gunn, D, Fried, R, Lalani, R et al. (22 more authors) (2019) Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial. Trials, 20. 517. ISSN 1745-6215
Lim, SJ, Gracie, DJ, Kane, JS et al. (5 more authors) (2019) Prevalence of, and predictors of, bile acid diarrhea in outpatients with chronic diarrhea: A follow-up study. Neurogastroenterology and Motility, 31 (9). e13666. ISSN 1350-1925
Burr, NE orcid.org/0000-0003-1988-2982 and Ford, AC orcid.org/0000-0001-6371-4359 (2019) Assessing the efficacy of peripherally acting µ-opioid receptor antagonists (PAMORAs) in the treatment of opioid-induced constipation: authors reply. Gut, 68 (8). pp. 1530-1531. ISSN 0017-5749
Ianiro, G, Eusebi, LH, Black, CJ et al. (3 more authors) (2019) Systematic review with meta-analysis: efficacy of faecal microbiota transplantation for the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 50 (3). pp. 240-248. ISSN 0269-2813
Gracie, DJ, Hamlin, PJ and Ford, AC orcid.org/0000-0001-6371-4359 (2019) The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment. The Lancet Gastroenterology and Hepatology, 4 (8). pp. 632-642. ISSN 2468-1253
Narula, N, Pinto-Sanchez, MI, Calo, NC et al. (4 more authors) (2019) Anxiety But Not Depression Predicts Poor Outcomes in Inflammatory Bowel Disease. Inflammatory bowel diseases, 25 (7). izy385. pp. 1255-1261. ISSN 1078-0998
Choy, MC, Seah, D, Faleck, DM et al. (10 more authors) (2019) Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis. Inflammatory bowel diseases, 25 (7). pp. 1169-1186. ISSN 1078-0998
O'Connor, A, Ratnakumaran, R, Warren, L et al. (6 more authors) (2019) Randomized controlled trial: a pilot study of a psychoeducational intervention for fatigue in patients with quiescent inflammatory bowel disease. Therapeutic Advances in Chronic Disease, 10. pp. 1-12. ISSN 2040-6223
Wu, IXY, Wong, CHL, Ho, RST et al. (6 more authors) (2019) Acupuncture and related therapies for treating irritable bowel syndrome: overview of systematic reviews and network meta-analysis. Therapeutic Advances in Gastroenterology, 12. pp. 1-34. ISSN 1756-283X
Ford, AC orcid.org/0000-0001-6371-4359, Lacy, BE, Harris, LA et al. (2 more authors) (2019) Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis. The American journal of gastroenterology, 114 (1). pp. 21-39. ISSN 0002-9270
Luthra, P, Burr, NE orcid.org/0000-0003-1988-2982, Brenner, DM et al. (1 more author) (2019) Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis. Gut, 68 (3). pp. 434-444. ISSN 0017-5749
Burr, NE orcid.org/0000-0003-1988-2982, Hall, B, Hamlin, PJ et al. (3 more authors) (2018) Systematic review and network meta-analysis Medical therapies to prevent recurrence of post-operative Crohn's disease. Journal of Crohn's & colitis. jjy216. ISSN 1873-9946
Black, CJ, Burr, NE orcid.org/0000-0003-1988-2982, Quigley, EMM et al. (3 more authors) (2018) Efficacy of Secretagogues in Patients With Irritable Bowel Syndrome With Constipation: Systematic Review and Network Meta-analysis. Gastroenterology, 155 (6). pp. 1753-1763. ISSN 0016-5085
Cheong, PK, Ford, AC orcid.org/0000-0001-6371-4359, Cheung, CKY et al. (5 more authors) (2018) Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial. The Lancet Gastroenterology and Hepatology, 3 (12). pp. 837-844. ISSN 2468-1253
Camilleri, M, Chedid, V, Ford, AC orcid.org/0000-0001-6371-4359 et al. (7 more authors) (2018) Gastroparesis. Nature reviews Disease primers, 4 (1). ARTN 41. 41-. ISSN 2056-676X
Ford, AC orcid.org/0000-0001-6371-4359, Harris, LA, Lacy, BE et al. (2 more authors) (2018) Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 48 (10). pp. 1044-1060. ISSN 0269-2813
Black, CJ, Houghton, LA and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Insights into the evaluation and management of dyspepsia: recent developments and new guidelines. Therapeutic Advances in Gastroenterology, 11. ISSN 1756-283X
Kane, JS, Irvine, AJ, Derwa, Y et al. (1 more author) (2018) Fatigue and its associated factors in microscopic colitis. Therapeutic Advances in Gastroenterology, 11. ISSN 1756-283X
Hall, BJ, Hamlin, PJ, Gracie, DJ et al. (1 more author) (2018) The Effect of Antidepressants on the Course of Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology, 2018. ARTN 2047242. ISSN 2291-2789
Dionne, J, Ford, AC orcid.org/0000-0001-6371-4359, Yuan, Y et al. (5 more authors) (2018) A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPs Diet in Treating Symptoms of Irritable Bowel Syndrome. American Journal of Gastroenterology, 113 (9). pp. 1290-1300. ISSN 0002-9270
Ford, AC orcid.org/0000-0001-6371-4359 (2018) Utility of the Oral Capsaicin Test in Diagnosing Functional Dyspepsia. The American Journal of Gastroenterology, 113. pp. 1257-1258. ISSN 0002-9270
Black, CJ and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis and clinical management. Medical Journal of Australia, 209 (2). pp. 86-91. ISSN 1326-5377
Ratnakumaran, R, Warren, L, Gracie, DJ orcid.org/0000-0001-9616-981X et al. (4 more authors) (2018) Fatigue in Inflammatory Bowel Disease Reflects Mood and Symptom-Reporting Behavior Rather Than Biochemical Activity or Anemia. Clinical Gastroenterology and Hepatology, 16 (7). pp. 1165-1167. ISSN 1542-3565
Ford, AC orcid.org/0000-0001-6371-4359, Moayyedi, P, Chey, WD et al. (4 more authors) (2018) American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. pp. 1-18. ISSN 0002-9270
Kane, JS, Irvine, AJ, Derwa, Y et al. (2 more authors) (2018) High prevalence of irritable bowel syndrome-type symptoms in microscopic colitis: implications for treatment. Therapeutic Advances in Gastroenterology, 11. pp. 1-12. ISSN 1756-283X
Shutkever, O, Gracie, DJ orcid.org/0000-0001-9616-981X, Young, C et al. (5 more authors) (2018) No Significant Association Between the Fecal Microbiome and the Presence of Irritable Bowel Syndrome-type Symptoms in Patients with Quiescent Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 24 (7). pp. 1597-1605. ISSN 1078-0998
Eusebi, LH and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Young GI angle: How to approach evidence-based medicine. United European Gastroenterology Journal, 6 (5). pp. 794-795. ISSN 2050-6406
Gracie, DJ orcid.org/0000-0001-9616-981X, Guthrie, EA orcid.org/0000-0002-5834-6616, Hamlin, PJ et al. (1 more author) (2018) Bi-directionality of Brain-Gut Interactions in Patients With Inflammatory Bowel Disease. Gastroenterology, 154 (6). pp. 1635-1646. ISSN 0016-5085
Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Defining the relationship between depression and disease activity in IBD using clinical disease activity indices: merit or misnomer? American Journal of Gastroenterology, 113. pp. 773-774. ISSN 0002-9270
Gracie, DJ orcid.org/0000-0001-9616-981X, Hamlin, PJ and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease. American Journal of Gastroenterology, 113. pp. 702-712. ISSN 0002-9270
Ratnakumaran, R, To, N, Gracie, DJ orcid.org/0000-0001-9616-981X et al. (8 more authors) (2018) Efficacy and tolerability of initiating, or switching to, infliximab biosimilar CT-P13 in inflammatory bowel disease (IBD): a large single-centre experience. Scandinavian Journal of Gastroenterology, 53 (6). pp. 700-707. ISSN 0036-5521
Sood, R and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Histologic Criteria to Define Irritable Bowel Syndrome: Within the Realms of Possibility? Gastroenterology, 154 (5). pp. 1539-1541. ISSN 0016-5085
Driver, RJ, Handforth, C, Radhakrishna, G et al. (3 more authors) (2018) The Glasgow Prognostic Score at the Time of Palliative Esophageal Stent Insertion is a Predictive Factor of 30-Day Mortality and Overall Survival. Journal of Clinical Gastroenterology, 52 (3). pp. 223-228. ISSN 0192-0790
Burr, NE orcid.org/0000-0003-1988-2982 and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Possible redundant data in the network meta-analysis of pharmacological therapies for opioid-induced constipation. Journal of Pain and Symptom Management, 55 (3). e8-e9. ISSN 0885-3924
Bradley, S orcid.org/0000-0002-2038-2056, Alderson, S orcid.org/0000-0002-5418-0495, Ford, AC orcid.org/0000-0001-6371-4359 et al. (1 more author) (2018) General practitioners’ perceptions of irritable bowel syndrome: a Q-methodological study. Family Practice, 35 (1). pp. 74-79. ISSN 0263-2136
Derwa, Y, Williams, CJM, Sood, R et al. (6 more authors) (2018) Factors affecting clinical decision-making in inflammatory bowel disease and the role of point-of-care calprotectin. Therapeutic Advances in Gastroenterology, 11. pp. 1-18. ISSN 1756-283X
Eusebi, LH, Ratnakumaran, R, Bazzoli, F et al. (1 more author) (2018) Prevalence of Dyspepsia in Individuals with Gastro-Esophageal Reflux-Type Symptoms in the Community: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 16 (1). 39-48e1. ISSN 1542-3565
Shearer, J, Luthra, P and Ford, AC orcid.org/0000-0001-6371-4359 (2018) Cyclic vomiting syndrome: a case series and review of the literature. Frontline Gastroenterology, 9 (1). pp. 2-9. ISSN 2041-4137
Eusebi, LH, Ratnakumaran, R, Yuan, Y et al. (3 more authors) (2018) Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis. Gut, 67 (3). pp. 430-440. ISSN 0017-5749
Sood, R orcid.org/0000-0003-1011-8910, Foy, R orcid.org/0000-0003-0605-7713 and Ford, AC orcid.org/0000-0001-6371-4359 (2017) Making a positive diagnosis of irritable bowel syndrome. British Journal of General Practice, 67 (665). pp. 580-581. ISSN 0960-1643
Camilleri, M and Ford, AC orcid.org/0000-0001-6371-4359 (2017) Pharmacotherapy for Irritable Bowel Syndrome. Journal of Clinical Medicine, 6 (11). 101. ISSN 2077-0383
Headlam, J, Ford, AC orcid.org/0000-0001-6371-4359 and Gracie, DJ orcid.org/0000-0001-9616-981X (2017) Reactive versus proactive therapeutic drug monitoring in IBD patients treated with infliximab: A self-fulfilling prophecy. Clinical Gastroenterology and Hepatology, 15 (10). p. 1638. ISSN 1542-3565
Appleton, ES, Lee, NA and Ford, AC orcid.org/0000-0001-6371-4359 (2017) Multiple myeloma presenting in association with gastric phytobezoar. Clinical Case Reports, 5 (9). pp. 1493-1495. ISSN 2050-0904
Gracie, DJ orcid.org/0000-0001-9616-981X, Williams, CJM, Sood, R orcid.org/0000-0003-1011-8910 et al. (4 more authors) (2017) IBS in IBD: A label to stick with caution - authors’ reply. Clinical Gastroenterology and Hepatology, 15 (8). pp. 1315-1316. ISSN 1542-3565
Pinto-Sanchez, MI, Hall, GB, Ghajar, K et al. (19 more authors) (2017) Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: a Pilot Study in Patients With Irritable Bowel Syndrome. Gastroenterology, 153 (2). 448-459.e8. ISSN 0016-5085
Pinto-Sánchez, MI, Causada-Calo, N, Bercik, P et al. (10 more authors) (2017) Safety of Adding Oats to a Gluten-free Diet for Patients with Celiac Disease: Systematic Review and Meta-analysis of Clinical and Observational Studies. Gastroenterology, 153 (2). pp. 395-409. ISSN 0016-5085
Kane, JS, Rotimi, O and Ford, AC (2017) Macroscopic findings, incidence and characteristics of microscopic colitis in a large cohort of patients from the United Kingdom. Scandinavian Journal of Gastroenterology, 52 (9). pp. 988-994. ISSN 0036-5521
Sood, R orcid.org/0000-0003-1011-8910, Gracie, DJ, Gold, MJ et al. (6 more authors) (2017) Derivation and validation of a diagnostic test for irritable bowel syndrome using latent class analysis. Alimentary Pharmacology and Therapeutics, 45 (6). pp. 824-832. ISSN 0269-2813
Gracie, DJ orcid.org/0000-0001-9616-981X, Irvine, AJ, Sood, R orcid.org/0000-0003-1011-8910 et al. (3 more authors) (2017) Effect of psychological therapy on disease activity, psychological comorbidity, and quality of life in inflammatory bowel disease: a systematic review and meta-analysis. Lancet Gastroenterology & Hepatology, 2 (3). pp. 189-199. ISSN 2468-1253
Ford, AC orcid.org/0000-0001-6371-4359, Luthra, P, Tack, J et al. (3 more authors) (2017) Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta-analysis. Gut, 66 (3). pp. 411-420. ISSN 0017-5749
Gracie, DJ orcid.org/0000-0001-9616-981X, Williams, CJM, Sood, R orcid.org/0000-0003-1011-8910 et al. (4 more authors) (2017) Negative Effects on Psychological Health and Quality of Life of Genuine Irritable Bowel Syndrome-type Symptoms in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 15 (3). 376-384.e5. ISSN 1542-3565
Simpkins, SJ, Pinto-Sanchez, MI, Moayyedi, P et al. (4 more authors) (2017) Poor predictive value of lower gastrointestinal alarm features in the diagnosis of colorectal cancer in 1981 patients in secondary care. Alimentary Pharmacology and Therapeutics, 45 (1). pp. 91-99. ISSN 0269-2813
Irvine, AJ, Chey, WD and Ford, AC orcid.org/0000-0001-6371-4359 (2017) Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis. American Journal of Gastroenterology, 112 (1). pp. 65-76. ISSN 0002-9270
Selinger, CP, Carbery, I, Warren, V et al. (8 more authors) (2017) The relationship between different information sources and disease-related patient knowledge and anxiety in patients with inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 45 (1). pp. 63-74. ISSN 0269-2813
Irvine, AJ, Pinto-Sanchez, MI, Bercik, P et al. (2 more authors) (2017) Minimal differences in prevalence and spectrum of organic disease at upper gastrointestinal endoscopy between selected secondary care patients with symptoms of gastro-oesophageal reflux or dyspepsia. Scandinavian Journal of Gastroenterology, 52 (4). pp. 396-402. ISSN 0036-5521
Sood, R orcid.org/0000-0003-1011-8910 and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Derivation and Validation of a Panel of Exhaled Volatile Organic Compounds in Differentiating Irritable Bowel Syndrome From Health. Gastroenterology, 151 (6). pp. 1245-1246. ISSN 0016-5085
Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Editorial: Using Patient-Reported Outcome Measures in Gastroenterology: PROMISed Land or Road to Nowhere? The American journal of Gastroenterology, 111 (11). pp. 1557-1558. ISSN 0002-9270
Gracie, DJ orcid.org/0000-0001-9616-981X and Ford, AC orcid.org/0000-0001-6371-4359 (2016) The possible risks of proton pump inhibitors. The Medical Journal of Australia, 205 (7). pp. 292-293. ISSN 0025-729X
Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Editorial: challenging established perceptions of brain–gut interactions in functional gastrointestinal disorders – brain–gut, gut–brain, or both? Alimentary Pharmacology and Therapeutics, 44 (8). pp. 899-900. ISSN 0269-2813
Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Depression Is Associated With Subjective Measures of Crohn's Disease Activity During Longitudinal Follow-up. Gastroenterology, 151 (4). pp. 762-763. ISSN 0016-5085
Sood, R orcid.org/0000-0003-1011-8910, Camilleri, M, Gracie, DJ et al. (4 more authors) (2016) Enhancing Diagnostic Performance of Symptom-Based Criteria for Irritable Bowel Syndrome by Additional History and Limited Diagnostic Evaluation. American Journal of Gastroenterology, 111 (10). pp. 1446-1454. ISSN 0002-9270
Luthra, P and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Screening for Celiac Disease in Individuals With Symptoms Suggestive of Irritable Bowel Syndrome: Still a Worthwhile Exercise. Gastroenterology, 151 (2). pp. 368-370. ISSN 0016-5085
Gracie, DJ and Ford, AC (2016) Psychological Comorbidity and Inflammatory Bowel Disease Activity: Cause or Effect? Clinical Gastroenterology and Hepatology, 14 (7). pp. 1061-1062. ISSN 1542-3565
To, N, Ford, AC and Gracie, DJ (2016) Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis. Alimentary Pharmacology and Therapeutics, 44 (2). pp. 117-126. ISSN 0269-2813
Kane, JS, Sood, R orcid.org/0000-0003-1011-8910, Law, GR orcid.org/0000-0001-7904-0264 et al. (4 more authors) (2016) Validation and modification of a diagnostic scoring system to predict microscopic colitis. Scandinavian Journal of Gastroenterology, 51 (10). pp. 1206-1212. ISSN 0036-5521
Kamp, EJ, Kane, JS and Ford, AC (2016) Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta-Analysis. Clinical Gastroenterology and Hepatology, 14 (5). pp. 659-668. ISSN 1542-7714
Gracie, DJ, Williams, CJM, Sood, R et al. (4 more authors) (2016) Poor correlation between clinical disease activity and mucosal inflammation, and the role of psychological comorbidity, in inflammatory bowel disease. American Journal of Gastroenterology, 111 (4). pp. 541-551. ISSN 0002-9270
Bidmead, TP and Ford, AC (2016) Antibiotic use and subsequent development of functional gastrointestinal disorders: effect of symptom-reporting and consultation behavior. Neurogastroenterology and Motility, 28 (3). pp. 449-450. ISSN 1350-1925
To, N, Gracie, DJ and Ford, AC orcid.org/0000-0001-6371-4359 (2016) Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Alimentary Pharmacology and Therapeutics, 43 (5). pp. 549-561. ISSN 0269-2813
To, N, Gracie, DJ and Ford, AC (2016) Letter: smoking as a modifiable risk factor for a complicated course in Crohn's disease. Alimentary Pharmacology and Therapeutics, 43 (3). p. 440. ISSN 0269-2813
Min, T and Ford, AC (2016) Efficacy of mesalazine in IBS. Gut, 65 (1). pp. 187-188. ISSN 0017-5749
Talley, NJ and Ford, AC orcid.org/0000-0001-6371-4359 (2015) Functional Dyspepsia. New England Journal of Medicine, 373 (19). pp. 1853-1863. ISSN 1533-4406
Ford, AC (2015) Is it Time to Rethink Screening of Individuals With Symptoms of Irritable Bowel Syndrome for Celiac Disease? Clinical Gastroenterology and Hepatology, 13 (11). pp. 1944-1945. ISSN 1542-3565
Sood, R orcid.org/0000-0003-1011-8910 and Ford, AC orcid.org/0000-0001-6371-4359 (2015) Use of Biomarkers in Irritable Bowel Syndrome: To Predict the Future, Look at the Past. Clinical and Translational Gastroenterology, 6 (10). e116. ISSN 2155-384X
Manship, TA and Ford, AC (2015) VSL#3 in Postoperative Crohn's Disease. Clinical Gastroenterology and Hepatology, 13 (10). p. 1855. ISSN 1542-3565
Aziz, I, Mumtaz, S, Bholah, H et al. (3 more authors) (2015) High Prevalence of Idiopathic Bile Acid Diarrhea Among Patients With Diarrhea-predominant Irritable Bowel Syndrome Based on Rome III Criteria. Clinical Gastroenterology and Hepatology, 13 (9). 1650 - 1655. ISSN 1542-3565
Gracie, DJ and Ford, AC (2015) Symbiotics in irritable bowel syndrome - better than probiotics alone? Current Opinion in Clinical Nutrition and Metabolic Care, 18 (5). pp. 485-489. ISSN 1363-1950
Sood, R, Gracie, DJ, Law, GR et al. (1 more author) (2015) Systematic review with meta-analysis: the accuracy of diagnosing irritable bowel syndrome with symptoms, biomarkers and/or psychological markers. Alimentary Pharmacology and Therapeutics, 42 (5). pp. 491-503. ISSN 0269-2813
Moayyedi, P, Quigley, EMM, Lacy, BE et al. (6 more authors) (2015) The Effect of Dietary Intervention on Irritable Bowel Syndrome: A Systematic Review. Clinical and Translational Gastroenterology, 6 (8). e107.
Davies, CL and Ford, AC (2015) Pinaverium in Irritable Bowel Syndrome: Old Drug, New Tricks? Clinical Gastroenterology and Hepatology, 13 (8). pp. 1548-1549. ISSN 1542-3565
Ford, AC orcid.org/0000-0001-6371-4359, Marwaha, A, Sood, R orcid.org/0000-0003-1011-8910 et al. (1 more author) (2015) Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut, 64 (7). pp. 1049-1057. ISSN 0017-5749
Slattery, SA, Niaz, O, Aziz, Q et al. (2 more authors) (2015) Systematic review with meta-analysis: The prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Alimentary Pharmacology and Therapeutics, 42 (1). pp. 3-11. ISSN 0269-2813
Sood, R orcid.org/0000-0003-1011-8910 and Ford, AC orcid.org/0000-0001-6371-4359 (2015) Combining biomarkers in irritable bowel syndrome: A forward step toward making a positive diagnosis and directing therapy? Gastroenterology, 148 (7). pp. 1471-1473. ISSN 0016-5085
Kane, JS, Rotimi, O, Everett, SM et al. (3 more authors) (2015) Development and Validation of a Scoring System to Identify Patients With Microscopic Colitis. Clinical Gastroenterology and Hepatology, 13 (6). pp. 1125-1131. ISSN 1542-3565
Dube, S and Ford, AC (2015) Efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 41 (11). pp. 1222-1223. ISSN 0269-2813
Quinn, JA and Ford, AC (2015) Comment on "A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome" by Guillaume Pineton de Chambrun et al. [Digestive and Liver Disease 2015;47:119-24]. Digestive and Liver Disease, 47 (5). p. 437. ISSN 1590-8658
Ford, AC, Moayyedi, P, Bercik, P et al. (4 more authors) (2015) Lack of utility of symptoms and signs at first presentation as predictors of inflammatory bowel disease in secondary care. American Journal of Gastroenterology, 110 (5). 716 - 724. ISSN 0002-9270
Gracie, DJ, Bercik, P, Morgan, DG et al. (4 more authors) (2015) No increase in prevalence of somatization in functional vs organic dyspepsia: A cross-sectional survey. Neurogastroenterology and Motility, 27 (7). 1034 - 1031. ISSN 1350-1925
Luthra, P, Peyrin-Biroulet, L and Ford, AC (2015) Systematic review and meta-analysis: Opportunistic infections and malignancies during treatment with anti-integrin antibodies in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics. ISSN 0269-2813
Patel, P, Bercik, P, Morgan, DG et al. (4 more authors) (2015) Irritable bowel syndrome is significantly associated with somatisation in 840 patients, which may drive bloating. Alimentary Pharmacology and Therapeutics, 41 (5). 449 - 458. ISSN 0269-2813
Gracie, DJ and Ford, AC (2015) IBS-like symptoms in patients with ulcerative colitis. Clinical and Experimental Gastroenterology, 8. 101 - 109. ISSN 1178-7023
Ford, AC, Luthra, P, Hanauer, SB et al. (3 more authors) (2014) Placebo response rate in clinical trials of fistulizing crohn's disease: systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 12 (12). 1981 - 1990. ISSN 1542-7714
Ford, AC, Quigley, EM, Lacy, BE et al. (6 more authors) (2014) Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis. American Journal of Gastroenterology, 109 (10). pp. 1547-1561. ISSN 0002-9270
Ford, AC orcid.org/0000-0001-6371-4359, Forman, D, Hunt, RH et al. (2 more authors) (2014) Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ, 348 (7959). g3174. ISSN 0959-8138
Ford, AC orcid.org/0000-0001-6371-4359, Bercik, P, Morgan, DG et al. (3 more authors) (2014) The Rome III Criteria for the Diagnosis of Functional Dyspepsia in Secondary Care Are Not Superior to Previous Definitions. Gastroenterology, 146 (4). pp. 932-940. ISSN 0016-5085
Ford, AC, Bercik, P, Morgan, DG et al. (3 more authors) (2013) Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology, 145 (6). 1262 - 1270. ISSN 0016-5085
Ford, AC, Talley, NJ, Spiegel, BMR et al. (4 more authors) (2008) Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ, 337 (7683). 1388 - 1392. ISSN 0959-8146
Conference or Workshop Item
Chang, L, Houghton, LA, Ford, AC et al. (6 more authors) (2021) Linaclotide Improves Symptoms of Irritable Bowel Syndrome With Constipation, Irrespective of Severity and Age: A Post-Hoc Analysis of Pooled Trials. In: 2021 ACG Annual Meeting, 21-26 Oct 2021, Las Vegas, NV.
Brenner, DM, Lacy, BE, Ford, AC et al. (6 more authors) (2021) Time to Relief of Key Abdominal and Bowel Symptoms of Irritable Bowel Syndrome with Constipation: A Post-Hoc Analysis of Randomized Controlled Trials of Linaclotide. In: 2021 ACG Annual Meeting, 21-26 Oct 2021, Las Vegas, NV.
Fairbrass, K, Hoshen, D, Ford, AC orcid.org/0000-0001-6371-4359 et al. (1 more author) (2020) P417: Do ACE inhibitors and angiotensin II receptor blockers improve disease outcomes in inflammatory bowel disease? In: 15th Congress of ECCO, 12-15 Feb 2020, Vienna, Austria.
Proceedings Paper
Nelson, AD, Black, C, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2021) Abdominal Bloating In Irritable Bowel Syndrome with Constipation: A Systematic Review and Network Meta-Analysis of FDA Approved Medications. In: Gastroenterology. Digestive Disease Week AGA Abstracts, 21-23 May 2021. Elsevier , S403-S404.
Black, C, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (4 more authors) (2021) Gastrointestinal symptom-specific anxiety and symptom severity in irritable bowel syndrome: new insights from factor analysis. In: Gut. Abstracts of the BSG Campus, 21-29 Jan 2021. BMJ , A35-A36.
Black, CJ, Yiannakou, Y, Houghton, LA orcid.org/0000-0002-5351-0229 et al. (3 more authors) (2021) Identification of novel subgroups in irritable bowel syndrome using latent class analysis: beyond stool form. In: Gut. Abstracts of the BSG Campus, 21-29 Jan 2021. BMJ , A208-A210.
Luthra, P, Burr, NE orcid.org/0000-0003-1988-2982, Brenner, DM et al. (1 more author) (2018) Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and network meta-analysis. In: Gut. BSG Annual Meeting, 05-08 Jun 2018, Liverpool, UK. BMJ , A216-A217.
Other
Littlehales, EG and Ford, AC (2015) Lubiprostone Is Effective in Treating Functional Bowel Disease With Constipation. Elsevier.
Luthra, P and Ford, AC (2015) Ondansetron and irritable bowel syndrome. BMJ Publishing Group.
Patel, P and Ford, AC (2015) Irritable bowel syndrome and somatization. Wiley.
Aziz, I, Kurien, M, Sanders, DS et al. (1 more author) (2015) Screening for bile acid diarrhoea in suspected irritable bowel syndrome. BMJ Publishing Group.
Ford, AC (2015) Aetiopathogenesis of functional dyspepsia. BMJ Publishing Group.